| dbo:abstract
|
- Abaloparatide, sold under the brand name Tymlos among others, is a parathyroid hormone-related protein (PTHrP) analog medication used to treat osteoporosis. It is an anabolic (i.e., bone growing) agent. In 2017, it was approved to treat postmenopausal osteoporosis in the United States. (en)
- Abaloparatyd (łac. abaloparatidum) – wielofunkcyjny organiczny związek chemiczny, rekombinowany ludzki peptyd podobny do parathormonu, agonista receptora PTH1, stosowany w leczeniu osteoporozy. (pl)
- BA058是一种用于治疗骨质疏松症的模拟药物。根据Radius公司所作的2期试验，该药物可以在半年内提升患者易骨折处的骨矿物质密度，耐受性、安全性的实验结果均受到肯定。目前正展开3期试验，包含了皮下注射形式的试验。 (zh)
|
| dbo:alternativeName
| |
| dbo:casNumber
| |
| dbo:chEMBL
| |
| dbo:drugbank
| |
| dbo:fdaUniiCode
| |
| dbo:kegg
| |
| dbo:medlinePlus
| |
| dbo:pubchem
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 21230 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:atcSuffix
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:chembl
| |
| dbp:chemspiderid
| |
| dbp:dailymedid
| |
| dbp:drugbank
| |
| dbp:h
| |
| dbp:iupacName
|
- L-alanyl-L-valyl-L-seryl-L-α-glutamyl-L-histidyl-L-glutaminyl-L-leucyl-L-leucyl-L-histidyl-L-α-aspartyl-L-lysylglycyl-L-lysyl-L-seryl-L-isoleucyl-L-glutaminyl-L-α-aspartyl-L-leucyl-L-arginyl-L-arginyl-L-arginyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-lysyl-L-leucyl-L-leucyl-2-methylalanyl-L-lysyl-L-leucyl-L-histidyl-L-threonyl-L-alaninamide (en)
|
| dbp:kegg
| |
| dbp:legalUs
| |
| dbp:medlineplus
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:smiles
|
- CC[C@H][C@@H]NC[C@H]NC[C@H]NCCNC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]NC[C@H]N (en)
|
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- BVISQZFBLRSESR-XSCWXTNMSA-N (en)
|
| dbp:synonyms
| |
| dbp:tradename
| |
| dbp:unii
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Abaloparatide, sold under the brand name Tymlos among others, is a parathyroid hormone-related protein (PTHrP) analog medication used to treat osteoporosis. It is an anabolic (i.e., bone growing) agent. In 2017, it was approved to treat postmenopausal osteoporosis in the United States. (en)
- Abaloparatyd (łac. abaloparatidum) – wielofunkcyjny organiczny związek chemiczny, rekombinowany ludzki peptyd podobny do parathormonu, agonista receptora PTH1, stosowany w leczeniu osteoporozy. (pl)
- BA058是一种用于治疗骨质疏松症的模拟药物。根据Radius公司所作的2期试验，该药物可以在半年内提升患者易骨折处的骨矿物质密度，耐受性、安全性的实验结果均受到肯定。目前正展开3期试验，包含了皮下注射形式的试验。 (zh)
|
| rdfs:label
|
- Abaloparatide (en)
- Abaloparatyd (pl)
- BA058 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
